Summary
Currently, blood products in China are totally divided into 9 categories from the type of product which is less than the developed countries. Besides, only several manufacturers can produce all the types at the same time. In recent years, the size of the market developed with an annual growth rate of 15%-20%. In 2007, the scale of China blood product market broke through 6 billion RMB Yuan mainly because of the annual growth of the human serum albumin market which takes 80% of China blood market. However, the demands of China blood product market can’t be well satisfied all along. An important reason is the short collection of the plasma raw materials caused by the policy factors. Domestic blood product manufacturers are small-scale enterprises basically, which has holdups including funds, technology, raw materials, and so on.
Compared to the global blood product market, China has a very small proportion. However with the sustained economic development and the enormous population, China market has tremendous potential.
This report analyzes China blood product market from various aspects such as production, supply and demand which makes investors understand the status of the market, the competition situation, as well as the profiles of the manufacturers. The report helps investors find investment opportunities, avoid investment risks and make right decisions.
Table of Contents
Executive Summary
1 Profiles of the global blood product market
1.1 Overview
1.1.1 Concepts of the blood product
1.1.2 Current situation of the global blood product industry
1.2 the product structure of the global blood product industry
1.2.1 Analysis on the product structure
1.2.2 Analysis on the trends
2 Profile of China blood product market
2.1 Current situation of China blood product market
2.1.1 Development courses of China blood product market
2.1.2 Analysis on sorts of China blood products
2.1.3 Market scale of China blood product market
2.1.4 Competing situation of China blood product market
2.2 Analysis on plasma raw materials
2.2.1 Overviews on gathering conditions of plasma raw materials
2.2.2 Analysis on securities
2.2.3 Analysis on major regions of gathering
2.3 Analysis on domestic blood product supplies and consume
2.4 Analysis on development environment of China blood product industry
2.4.1 Macroeconomic environment
2.4.2 Policy environment
2.4.3 Barriers of entry
3 Analysis on major blood products in China
3.1 Analysis on the current utilization of blood products in China
3.1.1 Analysis on comprehensive utilization of plasma
3.1.2 Overview on major blood products in China
3.2 Subdivision of major blood products in China
3.2.1 Albumin products
3.2.2 Immunoglobulin products
3.2.3 Blood clotting factor products
3.2.4 Analysis on the product trends
3.3 Analysis on imports and exports of blood products in China
3.3.1 Imports
3.3.2 Exports
4 Analysis on major blood product manufacturers in China
4.1 Hualan Biological Engineering Inc.
4.1.1 Profiles
4.1.2 Operational situation
4.1.3 Strategies
4.2 Shanghai Institute of Biological Products (SIBP)
4.3 Rongsheng Pharmaceuticals
4.4 Shanghai RAAS Blood Products Co., Ltd.
4.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
4.6 Shanghai Xinxing medicine Co., Ltd.
4.7 Zhejiang Haikang Biology Products Limited Responsibility Company
4.8 Xi’an Hui Tian Blood Products Co.,Ltd.
4.9 Zhongtai Pharmaceutical
4.10 Shengzhen WEIWU GUANGMING Biological Products Co., Ltd.
4.11 Beijing Tiantan Biological Products Co., Ltd.
4.12 Green Cross China Biological Product Co., Ltd.
4.13 Shandong Taibang Biological Product Co., Ltd.
4.14 Jiangxi Boya Biological Pharmaceuticals
4.15 Guiyang Qianfeng Biological Product Co., Ltd.
5 Analysis on mergers and reorganizations of China blood product industry
5.1 Backgrounds of mergers and reorganizations
5.2 Cases of mergers and reorganizations
5.3 Analysis on trends of mergers and reorganizations
6 Analysis on development and investment of China blood product industry
6.1 Analysis on development of China blood product industry
6.2 Analysis on investment risks of China blood product industry
6.2.1 Security hazards
6.2.2 Raw material risks
6.2.3 Other risks
6.2.4 Recommendations on risk aversion
6.3 Analysis on investment opportunities of China blood product industry
6.4 Recommendations on investment in China blood product industry
Partial Charts
Chart Major product sorts of the global blood product industry
Chart Global market scales of blood products, 2003-2007
Chart Major product sorts of China blood product industry
Chart Product structure of China blood product industry in 2007
Chart Domestic market scales of human serum albumin products, 2001-2007
Chart Plasma volumes of China blood product industry, 2003-2007
Chart Analysis on major regions of gathering plasma in 2007
Chart Ton plasma revenue of major blood product manufacturers in China in 2007
Chart Prices of human serum albumin products in China, 2002-2007
Chart Outputs of human serum albumin products in China, 2005-2007
Chart Outputs of selected immune globulin products in China, 2007
Chart Introduction on major blood products of Hualan Biological Engineering Inc.
Chart Operational situations of Hualan Biological Engineering Inc., 2003-2007
Chart Major products of Shanghai RAAS Blood Products Co., Ltd.
Chart Operational situations of Beijing Tiantan Biological Products Co., Ltd., 2003-2007
Companies Mentioned
Hualan Biological Engineering Inc.
Shanghai Institute of Biological Products (SIBP)
Rongsheng Pharmaceuticals
Shanghai RAAS Blood Products Co., Ltd.
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
Shanghai Xinxing medicine Co., Ltd.
Zhejiang Haikang Biology Products Limited Responsibility Company
Xi’an Hui Tian Blood Products Co.,Ltd.
Zhongtai Pharmaceutical
Others
